Andres F. Ramirez-Gamero

Internal Medicine
3024 New Bern Ave Ste 304
Raleigh, NC 27610

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenström's Macroglobulinemia.

WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenström's Macroglobulinemia.

Journal: Blood cancer journal
Published: January 20, 2026

Supportive Care Interventions in Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis.

Supportive Care Interventions in Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis.

Journal: Blood advances
Published: January 14, 2026

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study.

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study.

Journal: Research square
Published: November 19, 2025

Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia.

Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia.

Journal: American journal of hematology
Published: November 10, 2025

Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia.

Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia.

Journal: Blood
Published: October 29, 2025

Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia.

Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia.

Journal: Blood
Published: October 29, 2025

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.

Journal: Blood cancer journal
Published: September 13, 2025

Familial clusters and clinical features, complications, and outcomes in 1000 patients with Waldenström macroglobulinemia.

Familial clusters and clinical features, complications, and outcomes in 1000 patients with Waldenström macroglobulinemia.

Journal: Blood advances
Published: June 05, 2025

Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia.

Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia.

Journal: Blood advances
Published: April 18, 2025

Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenström macroglobulinemia: a pooled analysis.

Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenström macroglobulinemia: a pooled analysis.

Journal: Blood advances
Published: March 18, 2025

Depth of Response From Fixed-Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia.

Depth of Response From Fixed-Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia.

Journal: American journal of hematology
Published: February 26, 2025

Zanubrutinib for the treatment of Bing-Neel syndrome.

Zanubrutinib for the treatment of Bing-Neel syndrome.

Journal: British journal of haematology
Published: December 04, 2024
Showing 1-12 of 14

Last Updated: 09/26/2026